Metastatic renal cell cancer treatments: An indirect comparison meta-analysis

BACKGROUND: Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved progression-free survival (PFS). We aimed to determine the relative effectiveness of new therapies in this field....

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Edward J, Rachlis, Beth, O'Regan, Chris, Thabane, Lehana, Perri, Dan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637892/
https://www.ncbi.nlm.nih.gov/pubmed/19173737
http://dx.doi.org/10.1186/1471-2407-9-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637892/
https://www.ncbi.nlm.nih.gov/pubmed/19173737
http://dx.doi.org/10.1186/1471-2407-9-34

Ejemplares similares